Merck invested $610mil in Absci. Merck's blockbust
Post# of 148187
(Total Views: 600)
Posted On: 07/26/2023 6:35:01 PM
Re: generactor #136225
Merck invested $610mil in Absci. Merck's blockbuster ($20.9bil in 2022) drug Keytruda is being mouse trialed at M.D. Anderson alongside Leronlimab. Keytruda's patent is approaching its expiration date (2028) and needs help to continue busting blocks. Dots to connect.
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼